Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Merck completes $1B North Carolina expansion — more growth on the way
Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...
Merck opens $1 billion addition in north Durham to boost production of popular vaccine
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...
Fierce Pharma7d
In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...
Merck set for patent battle with Halozyme over injectable Keytruda: WSJ
Merck (MRK) stock trended lower as Halozyme (HALO) challenges the company over injectable Keytruda patents. Read more here.
Merck's Oncology Strength: Beating Wall Street Again
Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK may work for income investors.
Merck & Co., Inc. (MRK) Among The Best Cheap Dividend Stock To Buy Right Now
We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look ...
I worked for USAID: If Congress does nothing, N.J.’s economy will also suffer.
USAID’s partnerships with New Jersey companies like Johnson & Johnson and Merck extend the state’s influence in global health ...
Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market
Vaccinex intends to file a Form 25 with the Securities and Exchange Commission on or about March 17, 2025 to remove its Common Stock from listing on Nasdaq.